The Jackson Laboratory in Bar Harbor is the first research institution in Maine to be awarded a grant of this type.

A new AI-powered program will allow researchers to level up their drug discovery efforts. The program, called TopoFormer, was developed by an interdisciplinary team led by Guowei Wei, a Michigan State ...

Tessel's contributions to the CATALYST program will accelerate the use of New Approach Methodologies (NAMs) for safer drug development through simulation. This work will also broaden the scope of ...

Organoid-on-chip technology merges patient-derived organoids with microfluidic engineering to recreate human physiology and predict drug responses with high precision. This innovation is reshaping ...

In April 2025, the U.S. Food and Drug Administration (FDA) released a landmark guidance titled “Roadmap to Reducing Animal Testing in Preclinical Safety Studies,” outlining its commitment to advancing ...

A discovery from Australian researchers could lead to better treatment for children with neuroblastoma, a cancer that ...

Drug repurposing shows promise in the treatment of retinal degenerations, according to a new study. A combination treatment incorporating three existing drugs -- tamsulosin, metoprolol and ...

When I met Ethan Nadelmann in the 1980s, on the eve of his creating the modern reform giant the Drug Policy Alliance, it seemed as though drug policy reform would be a way out of America’s ...